Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis

IMPORTANCE: Therapeutic options for patients with secondary progressive multiple sclerosis (SPMS) are limited. OBJECTIVE: To analyze disability progression in patients with SPMS treated with rituximab compared with matched control patients never treated with rituximab. DESIGN, SETTING, AND PARTICIPA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Neurol
Hlavní autoři: Naegelin, Yvonne, Naegelin, Peter, von Felten, Stefanie, Lorscheider, Johannes, Sonder, Judith, Uitdehaag, Bernard M. J., Scotti, Barbara, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Derfuss, Tobias
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2019
Témata:
Original Investigation
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439730/
https://ncbi.nlm.nih.gov/pubmed/30615019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaneurol.2018.4239
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky